A Prognostic Score for Patients with Acute Leukemia or Myelodysplastic Syndromes Undergoing Allogeneic Stem Cell Transplantation
Open Access
- 31 January 2008
- journal article
- research article
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 14 (1), 28-35
- https://doi.org/10.1016/j.bbmt.2007.07.016
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Impact of Cytogenetics on Outcome of De Novo and Therapy-Related AML and MDS after Allogeneic TransplantationTransplantation and Cellular Therapy, 2007
- Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantationBlood, 2007
- Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?Blood, 2006
- Optimization of Transplant Regimens for Patients with Myelodysplastic Syndrome (MDS)Hematology-American Society Hematology Education Program, 2005
- Role of Allogeneic Stem Cell Transplantation in Current Treatment of Acute Myeloid LeukemiaHematology-American Society Hematology Education Program, 2005
- Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantationBone Marrow Transplantation, 2002
- Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantationThe Lancet, 1998
- Proportional hazards tests and diagnostics based on weighted residualsBiometrika, 1994
- A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing RiskThe Annals of Statistics, 1988
- Regression modelling strategies for improved prognostic predictionStatistics in Medicine, 1984